Virtual Grand Rounds

While psychedelic therapy is still controversial and not considered the standard of care, the subject has seen increasing interest by both the media and patients. In this Virtual Grand Rounds, Joshua Woolley, M.D., Ph.D., will discuss the current state of psychedelic therapy including clinical evidence, legal status, long-term data and regulatory factors. Additionally, California Department of Public Health Director Erica Pan, M.D., MPH, will discuss the winter respiratory virus season as well as other important emerging public health issues. Featured Speakers: --Erica Pan, M.D., MPH, Director, California Department of Public Health, State Public Health Officer --Joshua Woolley, M.D., PhD, Associate Professor Psychiatry, University of California - San Francisco, Weill Institute for Neurosciences This event will be moderated by Kimberly Newell-Green, M.D. --Kimberly Newell Green, M.D., CMA Trustee; Associate Clinical Professor, University of California, San Francisco As a result of this activity, participants should be able to: --Analyze current epidemiologic trends of COVID-19, measles, avian influenza, and other emerging infectious diseases. --Evaluate the clinical evidence supporting the efficacy of psychedelic therapy for various clinical indications. --Appraise available short- and long-term safety and outcome data related to psychedelic therapy. --Explain the current legal and regulatory frameworks governing the clinical delivery of psychedelic therapy. --Recognize that psychedelic therapy is still controversial and not standard of care. Disclosure: Joshua Woolley, M.D., PhD has disclosed the following relevant relationships: Consulting for Mindmed and being an expert witness for Terran Biosciences. These relationships have been mitigated. The following speakers disclose no relevant financial relationships with ineligible companies: Kimberly Newell-Green, M.D.; Erica Pan, M.D., MPH; All other planners, staff and others involved with this activity have reported no relevant financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. This activity has not received commercial support. This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the California Medical Association (CMA) and the California Department of Public Health. CMA is accredited by ACCME to provide continuing medical education for physicians. The California Medical Association designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1 MOC point in the American Board of Pediatrics' (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion to ACCME for the purpose of granting ABP MOC credit Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1 MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion to ACCME for the purpose of granting ABIM MOC credit Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the General CME and Self-Assessment requirements of the American Board of Surgery's Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion to ACCME for the purpose of granting ABS MOC credit.

Location Information

Webinar

Sacramento, CA

Get directions